EcoDrugPlus

5-Hydroxytryptamine Receptor 7-Like

Ensembl ID : ENSOKIG00005041651
Gene Symbol: LOC109866064
2 Cross references
190 Possible Orthologues:

60s Acidic Ribosomal Protein P0

Ensembl ID : ENSOKIG00005023463
Gene Symbol: LOC109893860
3 Cross references
393 Possible Orthologues:

60s Acidic Ribosomal Protein P1

Ensembl ID : ENSOKIG00005007285
Gene Symbol: LOC109903424
3 Cross references
363 Possible Orthologues:

60s Acidic Ribosomal Protein P1-Like

Ensembl ID : ENSOKIG00005012592
Gene Symbol: LOC109907171
3 Cross references
361 Possible Orthologues:

60s Ribosomal Protein L10a

Ensembl ID : ENSOKIG00005011685
Gene Symbol: LOC109891319
3 Cross references
363 Possible Orthologues:

60s Ribosomal Protein L11

Ensembl ID : ENSOKIG00005048241
Gene Symbol: LOC109907586
3 Cross references
282 Possible Orthologues:

60s Ribosomal Protein L13

Ensembl ID : ENSOKIG00005048367
Gene Symbol: LOC109887590
3 Cross references
269 Possible Orthologues:

60s Ribosomal Protein L13

Ensembl ID : ENSOKIG00005045137
Gene Symbol: LOC109895399
3 Cross references
269 Possible Orthologues:

60s Ribosomal Protein L13a

Ensembl ID : ENSOKIG00005003267
Gene Symbol: LOC109894672
3 Cross references
363 Possible Orthologues:

60s Ribosomal Protein L14

Ensembl ID : ENSOKIG00005029882
Gene Symbol: LOC109876522
3 Cross references
303 Possible Orthologues:

60s Ribosomal Protein L15

Ensembl ID : ENSOKIG00005020061
Gene Symbol: LOC109907378
3 Cross references
352 Possible Orthologues:

60s Ribosomal Protein L15

Ensembl ID : ENSOKIG00005034488
Gene Symbol: LOC109903490
3 Cross references
352 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).